TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Innoviva Says It Fends Off Sarissa Dissidents
MERGERS AND ACQUISITIONS

Innoviva Says It Fends Off Sarissa Dissidents

  • By Armie Margaret Lee
  • Apr 20, 2017 11:17 PM EDT
PRESS RELEASES

Armata Pharmaceuticals Announces $20 Million Investment To Support Advancement Of The Company's Bacteriophage Development Programs

  • By PR Newswire
  • Jan 27, 2021 7:01 AM EST
PRESS RELEASES

FDA Approves Trelegy Ellipta As The First Once-Daily Single Inhaler Triple Therapy For The Treatment Of Both Asthma And COPD In The US

  • By Business Wire
  • Sep 9, 2020 6:45 PM EDT
PRESS RELEASES

FDA Approves Trelegy Ellipta As The First Once-Daily Single Inhaler Triple Therapy For The Treatment Of Both Asthma And COPD In The US

  • By Business Wire
  • Sep 9, 2020 6:24 PM EDT
PRESS RELEASES

Innoviva Names Pavel Raifeld As Chief Executive Officer

  • By Business Wire
  • May 21, 2020 4:05 PM EDT
PRESS RELEASES

Innoviva Announces Change Of Location Of Annual Meeting Of Stockholders To Be Held On April 24, 2020

  • By Business Wire
  • Mar 31, 2020 4:05 PM EDT
PRESS RELEASES

GSK Filing Accepted By European Medicines Agency For Trelegy Ellipta Use In Adult Patients With Asthma

  • By Business Wire
  • Feb 27, 2020 9:36 AM EST
PRESS RELEASES

Armata Pharmaceuticals Announces Closing Of First Tranche Of Recently Executed $25 Million Securities Purchase Agreement With Innoviva, Inc.

  • By PR Newswire
  • Feb 13, 2020 8:00 AM EST
PRESS RELEASES

Armata Pharmaceuticals And Innoviva Announce $25 Million Strategic Investment To Support Advancement Of Armata's Bacteriophage Development Programs

  • By PR Newswire
  • Jan 28, 2020 7:00 AM EST
Innoviva Says It Fends Off Sarissa Dissidents
MERGERS AND ACQUISITIONS

Innoviva Says It Fends Off Sarissa Dissidents

  • By Armie Margaret Lee
  • Apr 20, 2017 11:17 PM EDT
Regeneron stock
MERGERS AND ACQUISITIONS

Sarissa names three its wants to seize Innoviva board seats

  • By William McConnell
  • Mar 13, 2017 5:17 PM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Premarket Movers: Innoviva, Akebia, Geron

  • By Armie Margaret Lee
  • Mar 7, 2017 9:28 AM EST
PE: More a Buyer Than a Seller This Year?
MERGERS AND ACQUISITIONS

Overboarded directors at valeant, yahoo! and elsewhere struggle with activists, m&a

  • By Ronald Orol
  • Aug 12, 2016 3:37 PM EDT
Today's Weak On High Volume Stock: Spirit AeroSystems Holdings (SPR)
MARKETS

Innoviva (INVA) Is Today's Strong On High Volume Stock

  • By TheStreet Wire
  • Jul 27, 2016 10:03 AM EDT
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

Trade-Ideas: Innoviva (INVA) Is Today's Weak On High Relative Volume Stock

  • By TheStreet Wire
  • Apr 27, 2016 10:03 AM EDT
Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER
OPINION

5 earnings stocks everyone hates -- but you should love

  • By Roberto Pedone
  • Apr 25, 2016 1:45 PM EDT
3 Leisure Stocks Pushing Industry Growth
MARKETS

Innoviva (INVA) Is Today's Dead Cat Bounce Stock

  • By TheStreet Wire
  • Feb 19, 2016 11:43 AM EST
MARKETS

Big Volume on the Big Board Sends Big-Caps Higher

  • By Joe Bousquin
  • Jun 16, 1998 6:22 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.